Capsida Company
Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.
Estimated Revenue:
$1M to $10M
Industry:
Early Drug Development
Investors Number:
3.0
Last Funding Date:
2023-02-23
Founded Date:
2019-01-01
Headquarters:
Newbury Park, California, United States
Total Funding:
140000000.0
Last Funding Type:
Corporate Round
Employee Number:
11-50